NEALS COVID-19 Statement
As the COVID-19 situation continues to evolve, we know it is of particular concern for the ALS community, both for clinical care and research trials. The health and safety of people living with ALS is always our top priority and we encourage everyone to follow recommendations from their state health department, the Centers for Disease Control (CDC), and the World Health Organization (WHO). The COVID-19 pandemic may impact clinical trials and we encourage each patient to contact their physician with any questions or concerns related to COVID-19.
Representatives from the NEALS leadership team hosted a webinar on March 27th on the impact of COVID-19 on ALS clinical research. Click here to access the recording and Q&A transcript.